[Industrial property and basic research in the genesis of the mRNA vaccine against COVID-19].

Migus A

DOI: 10.1016/j.banm.2022.06.014
Published: 2022 Dec
Container: Bulletin de l'Academie nationale de medecine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.banm.2022.06.014,
  title = {[Industrial property and basic research in the genesis of the mRNA vaccine against COVID-19].},
  author = {Migus A},
  year = {2022},
  journal = {Bulletin de l'Academie nationale de medecine},
  doi = {10.1016/j.banm.2022.06.014},
  url = {https://doi.org/10.1016/j.banm.2022.06.014}
}

RIS

TY  - JOUR
TI  - [Industrial property and basic research in the genesis of the mRNA vaccine against COVID-19].
AU  - Migus A
PY  - 2022
JO  - Bulletin de l'Academie nationale de medecine
DO  - 10.1016/j.banm.2022.06.014
UR  - https://doi.org/10.1016/j.banm.2022.06.014
ER  -

APA

A, M. (2022). [Industrial property and basic research in the genesis of the mRNA vaccine against COVID-19].. Bulletin de l'Academie nationale de medecine. https://doi.org/10.1016/j.banm.2022.06.014

Source records

pubmed · retrieved 2026-09-25T20:22:48.673Z